ReviewPharmacology, biochemistry, and behavior2011
Cognitive enhancers for anxiety disorders.
Review in Pharmacology, biochemistry, and behavior, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.
- Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.Journal of anxiety disorders · 2019Pooled it
- Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders.The Cochrane database of systematic reviews · 2015Pooled it
- D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables.Journal of consulting and clinical psychology · 2013Trial
- D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.Journal of psychiatric research · 2013Trial
- D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.The American journal of psychiatry · 2013Trial
- D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.Biological psychiatry · 2013Trial
- Augmentation of exposure therapy with post-session administration of D-cycloserine.Journal of psychiatric research · 2013Trial
- The effect of D-cycloserine on subliminal cue exposure in spider fearful individuals.Cognitive behaviour therapy · 2012Trial
- Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024.F1000Research · 2025Article
- Photobiomodulation mechanisms: duration of action in the human prefrontal cortex.Frontiers in behavioral neuroscience · 2025Article
- Solriamfetol enhances wakefulness and improves cognition and anxiety in a murine model of OSA.Sleep medicine · 2023Article
- Article
- Elevated activity in the dorsal dentate gyrus reduces expression of fear memory after fear extinction training.Journal of psychiatry & neuroscience : JPN · 2021Article
- Transcranial Electric Stimulation and the Extinction of Fear.The Clinical psychologist · 2020Article
- Mathematics Anxiety, Working Memory, and Mathematics Performance in Secondary-School Children.Frontiers in psychology · 2016Article
- Vagus Nerve Stimulation Enhances Extinction of Conditioned Fear in Rats and Modulates Arc Protein, CaMKII, and GluN2B-Containing NMDA Receptors in the Basolateral Amygdala.Neural plasticity · 2016Article
- Opposing effects of D-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior.Neurobiology of learning and memory · 2014Article
- Improving Outcome of Psychosocial Treatments by Enhancing Memory and Learning.Perspectives on psychological science : a journal of the Association for Psychological Science · 2014Article
- A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder.BMC psychology · 2014Article
- The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related Disorders.Current psychiatry reviews · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
Cognitive-behavioral therapy is an effective intervention for anxiety disorders. However, a significant number of people do not respond or only show partial response even after an adequate course of the treatment. Recent research has shown that the efficacy of the intervention can be improved by the use of cognitive enhancers that augment the core learning processes of cognitive-behavior therapy. This manuscript provides a review of the current state of cognitive enhancers for the treatment of anxiety disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.